Valence Health is a technology company.
Valence Health has raised $15.0M across 1 funding round.
Valence Health has raised $15.0M in total across 1 funding round.
Valence Health was a technology company specializing in value-based care solutions for healthcare providers. Founded in 1996, it offered an integrated platform of advisory services, population health technology, and managed services to help hospitals, health systems, and physicians manage patient populations effectively, achieving clinical and financial rewards.[2][3][5] Supporting over 85,000 physicians and 135 hospitals across 20+ million patients, Valence focused on transitioning providers from volume-based to value-based care through tailored solutions like governance models, network development, care management, and reimbursement support.[2] The company raised $45M before being acquired by Evolent Health in 2016, extending Evolent's capabilities in population health and value-based care.[3][5]
Note: A separate entity, Vālenz Health (with an accent), operates today as a platform simplifying self-insurance for employers, payers, and providers, focusing on cost containment and utilization data—likely a rebrand or successor post-acquisition.[4] Valence Surface Technologies is unrelated, providing metal finishing for medical devices.[1]
Valence Health emerged in 1996 amid the shift toward managed care and population health management in U.S. healthcare. For two decades, it built expertise helping providers navigate this transition, starting with advisory services and evolving into comprehensive tech-enabled solutions.[2][3] Key leadership included experienced healthcare executives, though specific founders are not detailed in available records; the company grew to serve major organizations nationwide with practical, market-specific tools.[2] A pivotal moment came in 2016 when Evolent Health acquired Valence to bolster its value-based care portfolio, integrating Valence's tech and services for broader reach.[5] This acquisition marked the end of Valence as an independent entity, with its legacy absorbed into Evolent's ecosystem.
Valence Health stood out in the digital health space through these key strengths:
Valence Health rode the early wave of value-based care trends in the 2010s, aligning with U.S. healthcare reforms like the Affordable Care Act that incentivized quality over volume. This timing was critical as providers faced pressure to manage populations amid rising costs, with Valence's tech enabling data analytics for better outcomes—foreshadowing today's AI-driven health platforms.[2][3] Market forces like payer-provider alignment and population health demands favored its model, influencing the ecosystem by proving scalable tech could bridge clinical and financial goals.[2][5] Post-acquisition, its DNA contributed to Evolent's growth in a digital health market now valued for platforms tackling unstructured data and consumer engagement.[3]
Valence Health's legacy endures through Evolent and potential evolutions like Vālenz Health, positioning it for ongoing relevance in self-insured and value-based models. Next steps likely involve deeper AI integration for predictive analytics and cost containment, shaped by trends like telehealth expansion and personalized care data sets.[3][4] As healthcare digitizes further, its influence could evolve toward unified platforms reducing fragmentation, empowering providers with real-time insights—reinforcing its role as a pioneer in making value-based care practical and scalable.[2]
Valence Health has raised $15.0M in total across 1 funding round.
Valence Health's investors include Endeavor Venture Funds, Flare Capital Partners, General Catalyst, GE Ventures.
Valence Health has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series B in November 2014.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2014 | $15.0M Series B | Endeavor Venture Funds, Flare Capital Partners, General Catalyst, GE Ventures |